Biomatlante SA - Product Pipeline Analysis, 2020 Update

Biomatlante SA - Product Pipeline Analysis, 2020 Update


Biomatlante SA (Biomatlante) operates as a biologics solutions provider that manufactures, develops, and commercializes synthetic bone graft technologies and synthetic biomaterials for bone regeneration. The company’s products include inserts, granules, sticks, wedges, syringes, putty, screw and membrane, among others. Its products are used in stomatology, dental regenerative, sports surgery, spine surgery and orthopaedics. Biomatlante’s leverages Micro Macroporous Biphasic Calcium Phosphate (MBCP) technology for the development of products. The company works in collaboration with universities and research centers such as National Institute of Health and Medical Research, French National Center for Scientific Research, and other national and international universities for the development of novel projects. Biomatlante is headquartered in Vigneux de Bretagne, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biomatlante SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Biomatlante SA Company Overview
Biomatlante SA Company Snapshot
Biomatlante SA Pipeline Products and Ongoing Clinical Trials Overview
Biomatlante SA – Pipeline Analysis Overview
Biomatlante SA - Key Facts
Biomatlante SA - Major Products and Services
Biomatlante SA Pipeline Products by Development Stage
Biomatlante SA Pipeline Products Overview
Biological Grafts
Biological Grafts Product Overview
Gene-Activated Matrix
Gene-Activated Matrix Product Overview
Hydrogels Product Overview
Osteoconductive Resorbable Composite
Osteoconductive Resorbable Composite Product Overview
Biomatlante SA - Key Competitors
Biomatlante SA - Key Employees
Biomatlante SA - Locations And Subsidiaries
Head Office
Recent Developments
Biomatlante SA, Recent Developments
Jun 01, 2015: BIOMATLANTE obtains CE approval to market its OSTEOTWIN Affix Sheath
Jan 17, 2013: Biomatlante Gets ANSM Approval For REBORNE Project
Oct 25, 2012: Biomatlante Announces Successful FDA QSIT Inspection
About GlobalData
Contact Us
List of Tables
Biomatlante SA Pipeline Products and Ongoing Clinical Trials Overview
Biomatlante SA Pipeline Products by Equipment Type
Biomatlante SA Pipeline Products by Indication
Biomatlante SA, Key Facts
Biomatlante SA, Major Products and Services
Biomatlante SA Number of Pipeline Products by Development Stage
Biomatlante SA Pipeline Products Summary by Development Stage
Biological Grafts - Product Status
Biological Grafts - Product Description
Gene-Activated Matrix - Product Status
Gene-Activated Matrix - Product Description
Hydrogels - Product Status
Hydrogels - Product Description
Osteoconductive Resorbable Composite - Product Status
Osteoconductive Resorbable Composite - Product Description
Biomatlante SA, Key Employees
List of Figures
Biomatlante SA Pipeline Products by Equipment Type
Biomatlante SA Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings